Prefusion Stabilized Spike Protein
Microtubules (Taxol Stabilized and Lyophilized) |
|||
MT002-A | Cytoskeleton | 4 x 500 µg | EUR 471.12 |
Human IgG antibody Laboratories manufactures the prefusion stabilized spike protein reagents distributed by Genprice. The Prefusion Stabilized Spike Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Prefusion products are available in stock. Specificity: Prefusion Category: Stabilized Group: Spike Protein
Mouse Monoclonal Anti-SARS Spike Protein IgG |
||
Alpha Diagnostics | 20 ug | EUR 489.6 |
Human SARS-CoV-2 Spike Protein IgG ELISA Kit |
||
Abbexa | 100 µg | EUR 593.75 |
Human SARS-CoV-2 Spike Protein S1 IgG (S1-IgG) ELISA Kit |
||
Sunlong | 96 Tests | EUR 468 |
Anti-Spike-RBD-fully-human-mAb(IgG) |
||
EnoGene | Human,-Human-IgG1.Affinity:(mol)4.15*10-10(Fortebio),-1.07-nM(ELISA).-FACs-Blocking:-0.892-nM- | EUR 416.5 |
Description: Human, Human IgG1.Affinity: (mol) 4.15*10-10 (Fortebio), 1.07 nM (ELISA) . FACs Blocking: 0.892 nM |
Anti-Spike-RBD-fully-human-mAb(IgG) |
||
EnoGene | Human,-Human-IgG1.Affinity:(mol)6.99*10-10(Fortebio),0.38-nM(ELISA).-FACs-Blocking:-0.803-nM- | EUR 416.5 |
Description: Human, Human IgG1.Affinity: (mol) 6.99*10-10 (Fortebio) , 0.38 nM (ELISA) . FACs Blocking: 0.803 nM |
Anti-Spike-RBD-fully-human-mAb(IgG) |
||
EnoGene | Human,-Human-IgG1.-Affinity:(mol)3.1*10-10(Fortebio)0.3-nM(ELISA).-FACs-Blocking:-0.889-nM. | EUR 416.5 |
Description: Human, Human IgG1. Affinity: (mol) 3.1*10-10 (Fortebio) 0.3 nM (ELISA) . FACs Blocking: 0.889 nM. |
Anti-Spike-RBD-fully-human-mAb(IgG) |
||
EnoGene | Humanized-Monoclonal-Antibody,-human-IgG1.-Affinity:0.561-nM(By-ELISA) | EUR 416.5 |
Description: Humanized Monoclonal Antibody, human IgG1. Affinity:0.561 nM (By ELISA) |
SARS-CoV-2 (B.1.351) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293): Biotin Conjugate |
|||
REC31963-Biotin-100 | The Native Antigen Company | 0.1 | EUR 718.25 |
Description: SARS-CoV-2 Spike protein, South African variant of concern. Relative to Wuhan-Hu-1 contains following amino acid changes: L18F, D80A, D215G, del242-244, K417N, E484K, N501Y, D614G, A701V. The protein contains six proline amino acid changes (commonly known as Hexapro) to stabilize it in a trimeric pre-fusion state. The furin cleavage site has been altered to 'SRAS' and deactivated. Protein is conjugated to biotin. |
SARS-CoV-2 (B.1.617.2; AY.1, AY.2, AY.3) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293) |
|||
REC31975-100 | The Native Antigen Company | 0.1 | EUR 636.6 |
Description: SARS-CoV-2 Spike protein containing following amino acid changes: T19R, T95I, G142D, E156G, del157-158, W258L, N417K, L452R, T478K, D614G, P681R, D950N. The protein is stabilized as a pre-fusion trimer due to six amino acid changes in the S2 portion of Spike (HexaPro). The furin cleavage site has been mutated to GSAS. |
SARS-CoV-2 (B.1.617.2; AY.1, AY.2, AY.3) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293) |
|||
REC31975-500 | The Native Antigen Company | 0.5 | EUR 2421.37 |
Description: SARS-CoV-2 Spike protein containing following amino acid changes: T19R, T95I, G142D, E156G, del157-158, W258L, N417K, L452R, T478K, D614G, P681R, D950N. The protein is stabilized as a pre-fusion trimer due to six amino acid changes in the S2 portion of Spike (HexaPro). The furin cleavage site has been mutated to GSAS. |
SARS-CoV-2 (C.37) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293): Biotin Conjugate |
|||
REC31976-Biotin-100 | The Native Antigen Company | 0.1 | EUR 718.25 |
Description: SARS-CoV-2 Spike protein containing following amino acid changes: G75V, T76I, 246-252del, D253N, L452Q, F490S, D614G, Q675H, T859N. The protein is stabilized as a pre-fusion trimer due to six amino acid changes in the S2 portion of Spike (HexaPro). The furin cleavage site has been mutated to GSAS. Protein is conjugated to biotin. |
SARS-CoV-2 (501.V2) Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293): Biotin Conjugate |
|||
REC31926-Biotin-100 | The Native Antigen Company | 0.1 | EUR 718.25 |
Description: SARS-CoV-2 HexaPro stabilized Spike glycoprotein containing amino acid changes in accordance with variant 501.V2 (“South African variant”): D80A, D215G, K417N, E484K, N501Y, A701V relative to Wuhan-Hu-1. This protein has the polybasic furin cleavage site “RRAR” changed to “SRAS” to prevent furin cleavage of the target protein. The protein also contains 6 amino acid changes to proline and a C-terminal T4 fibritin trimerization domain to stabilize the protein in its pre-fusion conformation as described in Hsieh, Goldsmith et al. 2020. The protein was produced in HEK293 and purified from culture supernatant. Protein is conjugated to biotin. |
SARS-CoV-2 (B.1.1.28) Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293): Biotin Conjugate |
|||
REC31944-Biotin-100 | The Native Antigen Company | 0.1 | EUR 718.25 |
Description: Pre-fusion stabilized SARS-CoV-2 Spike protein of the virus variant B.1.1.28 (P1, Brazilian variant) containing amino acid changes L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I, V1176F relative to Wuhan Hu-1. The protein was produced in HEK293 cells and purified from culture supernatant. The protein was stabilized using HexaPro as described in Hsieh, Goldsmith et al. 2020. Protein is conjugated to biotin. |
SARS-CoV-2 (B.1.1.529/Omicron) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293): Biotin Conjugate |
|||
REC32008-Biotin-100 | The Native Antigen Company | 0.1 | EUR 718.25 |
Description: Recombinant SARS-CoV-2 Omicron variant Spike protein. Relative to Wuhan-Hu-1 the protein has following amino acid changes: A67V, H69del, V70del, T95I, G142D, V143del, Y144del, Y145del, N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F. The furin cleavage site has been altered to GSAS, and the protein has 6 amino acid changes in the S2 portion to stabilize trimer formation, commonly known as HexaPro. The C-terminus contains a T4 foldon domain. Protein is biotinylated. |
SARS-CoV-2 (B.1.1.529/Omicron) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293): Biotin Conjugate |
|||
REC32008-Biotin-500 | The Native Antigen Company | 0.5 | EUR 3268.47 |
Description: Recombinant SARS-CoV-2 Omicron variant Spike protein. Relative to Wuhan-Hu-1 the protein has following amino acid changes: A67V, H69del, V70del, T95I, G142D, V143del, Y144del, Y145del, N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F. The furin cleavage site has been altered to GSAS, and the protein has 6 amino acid changes in the S2 portion to stabilize trimer formation, commonly known as HexaPro. The C-terminus contains a T4 foldon domain. Protein is biotinylated. |
Streptolysin O protein (Stabilized) |
|||
30-1023 | Fitzgerald | 1 mg | EUR 575 |
Description: Purified recombinant stabilized Human Streptolysin O protein |
SARS-CoV-2 (B.1.617.2; AY.1, AY.2, AY.3) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293): Biotin Conjugate |
|||
REC31975-Biotin-100 | The Native Antigen Company | 0.1 | EUR 718.25 |
Description: SARS-CoV-2 Spike protein containing following amino acid changes: T19R, T95I, G142D, E156G, del157-158, W258L, N417K, L452R, T478K, D614G, P681R, D950N. The protein is stabilized as a pre-fusion trimer due to six amino acid changes in the S2 portion of Spike (HexaPro). The furin cleavage site has been mutated to GSAS. Protein is conjugated to biotin. |
Stabilized Troponin I protein (Cardiac) |
|||
30-1003 | Fitzgerald | 100 ug | EUR 1163 |
Description: Purified recombinant Human Stabilized Troponin I protein (Cardiac) |
SARS-CoV-2 (COVID-19) S1+S2 ECD (S-ECD), (Wild type,pre-fusion state) Recombinant Protein |
|||
10-122 | ProSci | 0.1 mg | EUR 789.9 |
Description: SARS-CoV-2 (COVID-19) S1+S2 ECD (S-ECD), (Wild type,pre-fusion state) Recombinant Protein |
Starch Stabilized 1% |
|||
40220144-1 | Bio-WORLD | 500 mL | Ask for price |
Starch Stabilized 1% |
|||
40220144-2 | Bio-WORLD | 1 L | Ask for price |
Starch Stabilized 1% |
|||
40220144-3 | Bio-WORLD | 4 L | Ask for price |
Grams Iodine, Stabilized |
|||
S057-125ML | EWC Diagnostics | 1 unit | EUR 9.17 |
Description: Grams Iodine, Stabilized |
Grams Iodine, Stabilized |
|||
S057-500ML | EWC Diagnostics | 1 unit | EUR 30.81 |
Description: Grams Iodine, Stabilized |